XYMOGEN 

CoQmax Omega 50 mg

Blend · 30 servings · $32.00 · 4.6 stars from 18 reviews

Worth trying for Cardiovascular support

Helps: Triglycerides

  • Evidence Worth trying
  • Dose 4 of 5 at a studied dose
  • Safety Read the label's warnings
  • Fillers None of concern

What's in it

4 of 5 actives reach a studied dose, and the shortfalls are minor.

Supplement Facts

Serving Size: 1 Softgel(s)

30 per container

† Daily Value not established

Other ingredients: Gelatin, Glycerin, Water, Purified, Roasted Carob powder, Yellow Beeswax, Mixed Tocopherols.

Directions: Take one softgel twice per day, or as directed by your healthcare professional.

at the studied dose below the studied range Every ingredient links to our evidence.

Doses against the trials

Worth knowing

The label's warnings

Consult your healthcare professional prior to use.

Individuals taking medication should discuss potential interactions with their healthcare professional.

Storage: Keep closed in a cool, dry place out of reach of children.

Contains: Fish (anchovy and/or sardine and/or mackerel).

Medicines its ingredients can clash with

Warfarin, Trazodone, Blood glucose lowering, Simvastatin, Aspirin, Tamoxifen, Raloxifene, Antithrombotic agents

Reported side effects

Death, Nausea, Diarrhea, Fishy burps, Gastrointestinal discomfort, Fishy aftertaste

The other ingredients

Clean formula. The inactive ingredients are standard capsule components.

  • Gelatin: capsule shell; neutral unless ethical concern
  • Glycerin: capsule plasticizer; benign
  • Water, Purified
  • Roasted Carob powder
  • Yellow Beeswax
  • Mixed Tocopherols: antioxidant; beneficial

Free from

Gluten Free, Dairy Free. Formulated to Exclude: Wheat, gluten, yeast, soy protein, dairy products, fish, shellfish, peanuts, tree nuts, egg, ingredients derived from genetically modified organisms (GMOs), artificial colors, artificial sweeteners, and artificial preservatives.

XYMOGEN 

80 out of 100

Brand audit score

XYMOGEN shows a solid quality posture with NSF Certified for Sport listings and public company disclosures, but the available evidence remains limited.